Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Other Accumulated Expenses (2022 - 2026)

HeartSciences (HSCS) has disclosed Other Accumulated Expenses for 4 consecutive years, with $148572.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses fell 14.44% year-over-year to $148572.0, compared with a TTM value of $148572.0 through Oct 2025, down 14.44%, and an annual FY2025 reading of $29927.0, down 12.36% over the prior year.
  • Other Accumulated Expenses was $148572.0 for Q4 2025 at HeartSciences, down from $215334.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $389186.0 in Q3 2022 and bottomed at $1220.0 in Q2 2022.
  • Average Other Accumulated Expenses over 4 years is $155938.1, with a median of $158620.0 recorded in 2023.
  • Peak annual rise in Other Accumulated Expenses hit 3883.28% in 2023, while the deepest fall reached 45.62% in 2023.
  • Year by year, Other Accumulated Expenses stood at $291670.0 in 2022, then plummeted by 45.62% to $158620.0 in 2023, then increased by 9.47% to $173644.0 in 2024, then decreased by 14.44% to $148572.0 in 2025.
  • Business Quant data shows Other Accumulated Expenses for HSCS at $148572.0 in Q4 2025, $215334.0 in Q3 2025, and $29927.0 in Q2 2025.